0,855  0,005  Caspase 9 stimulant
0,699  0,031  Antiinflammatory
0,670  0,004  Restenosis treatment
0,650  0,010  Antiallergic
0,640  0,006  Hypoglycemic
0,637  0,011  5 Hydroxytryptamine release stimulant
0,618  0,010  Antioxidant
0,595  0,003  5 Hydroxytryptamine uptake stimulant
0,595  0,007  Antimutagenic
0,595  0,012  Cardiovascular analeptic
0,609  0,030  Transcription factor NF kappa B inhibitor
0,585  0,014  Chemopreventive
0,590  0,020  Aldehyde oxidase inhibitor
0,577  0,008  Platelet antagonist
0,586  0,020  Cholesterol antagonist
0,578  0,012  Caspase 3 stimulant
0,579  0,013  UGT1A9 substrate
0,592  0,026  TNF expression inhibitor
0,611  0,047  Apoptosis agonist
0,543  0,006  Genotoxic
0,549  0,014  NOS2 expression inhibitor
0,552  0,017  CTGF expression inhibitor
0,554  0,020  Vasodilator, peripheral
0,529  0,004  VCAM1 expression inhibitor
0,578  0,059  Alpha-glucosidase inhibitor
0,529  0,014  Nitric oxide antagonist
0,519  0,008  UGT2B4 substrate
0,510  0,004  Pneumotoxic
0,516  0,015  Free radical scavenger
0,539  0,040  Cyclophilin D inhibitor
0,539  0,040  Antidiabetic
0,496  0,004  Neurotrophic factor enhancer
0,508  0,018  Lipoxygenase inhibitor
0,488  0,006  Amylase inhibitor
0,495  0,013  UGT1A6 substrate
0,498  0,025  Cytotoxic
0,521  0,049  Antineoplastic (breast cancer)
0,481  0,011  UGT1A1 substrate
0,466  0,013  Antihypoxic
0,489  0,037  Antineoplastic (colorectal cancer)
0,473  0,023  Cytostatic
0,490  0,043  GST A substrate
0,456  0,010  Cyclic AMP phosphodiesterase inhibitor
0,463  0,018  Hypoxia-inducible factor 1 alpha inhibitor
0,482  0,039  Antipruritic, allergic
0,469  0,028  Spasmolytic
0,471  0,034  Antithrombotic
0,437  0,007  GST M1-1 substrate
0,461  0,032  Antihypercholesterolemic
0,466  0,038  Prostate cancer treatment
0,466  0,038  Antineoplastic (colon cancer)
0,454  0,030  Hepatic disorders treatment
0,438  0,014  Platelet aggregation inhibitor
0,454  0,031  Antifungal
0,466  0,046  Antileukemic
0,445  0,030  Antineoplastic (cervical cancer)
0,447  0,037  Bone diseases treatment
0,414  0,008  UGT2B15 substrate
0,447  0,041  CYP2C19 inhibitor
0,428  0,030  ICAM1 expression inhibitor
0,411  0,014  UGT1A4 substrate
0,404  0,008  GST P1-1 substrate
0,424  0,032  Apoptosis antagonist
0,410  0,019  UDP-glucuronosyltransferase substrate
0,401  0,011  UGT2B7 substrate
0,440  0,055  Histamine release inhibitor
0,414  0,030  Sensitization
0,405  0,022  Antimitotic
0,417  0,036  AR expression inhibitor
0,438  0,057  Calcium channel L-type activator
0,438  0,058  15-Lipoxygenase inhibitor
0,408  0,036  Cardioprotectant
0,395  0,030  Proliferative diseases treatment
0,400  0,039  NOS3 expression inhibitor
0,374  0,013  UGT1A3 substrate
0,370  0,014  Melanin inhibitor
0,393  0,039  Antiosteoporotic
0,368  0,014  Skin whitener
0,408  0,055  Ulceration
0,388  0,036  Chemoprotective
0,393  0,042  CYP2C19 substrate
0,355  0,004  Estrogen agonist
0,360  0,011  Protein kinase stimulant
0,380  0,031  Antipyretic
0,355  0,008  Glutathione S-transferase substrate
0,365  0,022  RNA-directed DNA polymerase inhibitor
0,385  0,043  Antineoplastic (melanoma)
0,356  0,018  Hepatoprotectant
0,384  0,048  Antineoplastic (ovarian cancer)
0,379  0,044  Lipoprotein disorders treatment
0,373  0,041  Antineoplastic (glioma)
0,349  0,019  Antiviral (Influenza)
0,348  0,018  Antihypotensive
0,360  0,035  Tumour necrosis factor alpha release inhibitor
0,368  0,047  Vasodilator, coronary
0,354  0,033  Amyloid beta aggregation inhibitor
0,352  0,033  Antiparasitic
0,323  0,004  VEGF expression inhibitor
0,387  0,067  CYP2C9 substrate
0,328  0,010  Sulfotransferase substrate
0,321  0,004  UGT2B10 substrate
0,385  0,069  Antineoplastic (lung cancer)
0,330  0,016  Interferon gamma antagonist
0,326  0,017  Tubulin antagonist
0,316  0,008  Nitric-oxide synthase stimulant
0,354  0,047  Calcium channel activator
0,386  0,083  Antibacterial
0,352  0,050  CYP1A2 substrate
0,339  0,038  Antineoplastic (glioblastoma multiforme)
0,309  0,009  Cystathionine beta-synthase inhibitor
0,348  0,052  Analeptic
0,322  0,027  Antihelmintic
0,338  0,046  Antineoplastic (non-small cell lung cancer)
0,345  0,057  Respiratory analeptic
0,340  0,055  Antineoplastic (brain cancer)
0,293  0,008  UGT2B1 substrate
0,301  0,018  Monophenol monooxygenase inhibitor
0,303  0,022  Antipruritic, non-allergic
0,310  0,033  Abortion inducer
0,287  0,011  SULT1A3 substrate
0,287  0,012  UGT2B9 substrate
0,319  0,045  Antineoplastic (lymphoma)
0,280  0,010  Expectorant
0,327  0,059  Antineoplastic (pancreatic cancer)
0,310  0,049  Antiamyloidogenic
0,308  0,046  Angiogenesis stimulant
0,274  0,014  Cholesterol synthesis inhibitor
0,295  0,038  Peroxidase inhibitor
0,283  0,029  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,324  0,069  CYP2D6 substrate
0,336  0,083  CYP3A4 substrate
0,265  0,015  LDLR expression enhancer
0,253  0,004  Estrogen receptor beta agonist
0,251  0,006  Mucolytic
0,269  0,027  Antineoplastic (squamous cell carcinoma)
0,307  0,065  Antineoplastic (osteosarcoma)
0,263  0,022  Antiviral (Influenza A)
0,256  0,015  5-Lipoxygenase inhibitor
0,285  0,048  Antineoplastic (sarcoma)
0,246  0,009  Histidine decarboxylase inhibitor
0,295  0,059  DNA damaging
0,285  0,049  DNA synthesis inhibitor
0,282  0,048  Psychostimulant
0,255  0,021  Succinate dehydrogenase inhibitor
0,251  0,017  Carcinogenic, group 1
0,259  0,026  Diabetic nephropathy treatment
0,311  0,081  FMO1 substrate
0,305  0,077  Immunostimulant
0,256  0,030  Antiviral (Herpes)
0,280  0,055  Vasodilator
0,228  0,004  Estrogen receptor alpha agonist
0,282  0,060  Antiprotozoal (Leishmania)
0,323  0,101  Immunosuppressant
0,236  0,015  Antihemorrhagic
0,236  0,014  Bronchodilator
0,270  0,051  Tyrosine 3 hydroxylase inhibitor
0,245  0,026  Bone formation stimulant
0,258  0,040  Non-steroidal antiinflammatory agent
0,227  0,010  Estrogen antagonist
0,305  0,090  Angiogenesis inhibitor
0,246  0,037  Insulin sensitizer
0,240  0,031  Skeletal muscle relaxant
0,217  0,008  Estrogen receptor beta antagonist
0,222  0,016  Arachidonic acid antagonist
0,266  0,061  Hypolipemic
0,269  0,064  Superoxide dismutase inhibitor
0,227  0,023  Antifungal enhancer
0,289  0,089  Sodium/bile acid cotransporter inhibitor
0,249  0,050  Platelet adhesion inhibitor
0,215  0,017  Microtubule formation inhibitor
0,216  0,021  Neurotrophic factor
0,199  0,005  Leukotriene synthesis inhibitor
0,209  0,020  Toll-Like receptor 2 antagonist
0,200  0,012  Vanilloid 1 agonist
0,227  0,039  Tumour necrosis factor antagonist
0,221  0,036  Antiparkinsonian, tremor relieving
0,261  0,076  Radiosensitizer
0,202  0,018  Carbonic anhydrase XV inhibitor
0,240  0,056  Mutagenic
0,242  0,060  Antihypertriglyceridemic
0,254  0,077  Antineoplastic (renal cancer)
0,219  0,043  Antihelmintic (Nematodes)
0,185  0,009  Macrophage migration inhibitory factor inhibitor
0,181  0,006  UGT2B11 substrate
0,219  0,045  Eye irritation, high
0,193  0,020  SULT1A1 substrate
0,249  0,076  Teratogen
0,209  0,038  Lipid peroxidase inhibitor
0,189  0,018  Carbonic anhydrase III inhibitor
0,183  0,013  Carcinogenic, group 2A
0,190  0,020  Beta amyloid protein antagonist
0,206  0,039  Aldehyde oxidase substrate
0,210  0,044  Acaricide
0,201  0,037  Antirickettsial
0,194  0,030  DNA polymerase I inhibitor
0,206  0,042  Antineoplastic (carcinoma)
0,192  0,029  Alkylator
0,186  0,024  Cyclooxygenase 3 inhibitor
0,220  0,060  DNA methyltransferase I inhibitor
0,234  0,075  Cardiodepressant
0,183  0,024  Adenylate cyclase stimulant
0,174  0,016  AMP-activated protein kinase stimulant
0,209  0,051  Muscle relaxant
0,179  0,021  Alcohol dehydrogenase substrate
0,179  0,025  Xanthine oxidase inhibitor
0,218  0,064  Carcinogenic
0,176  0,023  Choleretic
0,268  0,116  Antineoplastic (small cell lung cancer)
0,219  0,067  DNA methylase inhibitor
0,188  0,038  Antiprotozoal (Coccidial)
0,229  0,079  Embryotoxic
0,153  0,005  Granulocyte macrophage colony stimulating factor agonist
0,157  0,009  Alpha tubulin antagonist
0,219  0,071  ErbB-1 antagonist
0,178  0,032  Topoisomerase I inhibitor
0,165  0,020  Antiviral (Influenza B)
0,152  0,009  Phosphodiesterase 6D inhibitor
0,161  0,019  Carbonic anhydrase VI inhibitor
0,171  0,030  Carcinogenic, group 2B
0,160  0,020  Creatine kinase inhibitor
0,227  0,086  Antineoplastic (liver cancer)
0,161  0,021  HIV-1 integrase (Overall Integration) inhibitor
0,162  0,025  Antineoplastic (uterine cancer)
0,153  0,018  Antifungal (Pneumocystis)
0,155  0,021  Carbonic anhydrase XIII inhibitor
0,189  0,056  Antianorexic
0,145  0,012  Postmenopausal disorders treatment
0,159  0,030  Gastritis treatment
0,155  0,026  Antineoplastic alkaloid
0,164  0,038  Platelet activating factor antagonist
0,146  0,020  NAD(P)H dehydrogenase (quinone) inhibitor
0,156  0,030  Ca2+-transporting ATPase inhibitor
0,140  0,015  HIV-1 integrase (3'-Processing) inhibitor
0,170  0,045  Alpha-N-acetylglucosaminidase inhibitor
0,223  0,100  Interleukin agonist
0,166  0,043  Topoisomerase II inhibitor
0,261  0,141  Antiasthmatic
0,174  0,054  NOS3 expression enhancer
0,169  0,050  Mannose-6-phosphate isomerase inhibitor
0,179  0,059  ATPase inhibitor
0,244  0,126  Interleukin 2 agonist
0,170  0,053  Aldose reductase substrate
0,138  0,021  NADH dehydrogenase inhibitor
0,164  0,047  Antiseptic
0,126  0,016  Vanilloid agonist
0,220  0,110  Radioprotector
0,176  0,067  Antineoplastic (bone cancer)
0,146  0,037  Papain-like protease (SARS coronavirus) inhibitor
0,139  0,032  Gastric antisecretory
0,170  0,062  Uterine stimulant
0,138  0,031  Beta glucuronidase inhibitor
0,139  0,033  UDP-glucose 4-epimerase inhibitor
0,123  0,018  Estrogen receptor alpha antagonist
0,252  0,148  Antineoplastic (endocrine cancer)
0,119  0,017  HIV-1 integrase (Strand Transfer) inhibitor
0,128  0,026  Platelet growth factor antagonist
0,120  0,019  ATPase (Vacuolar H+) inhibitor
0,130  0,029  GST T1-1 substrate
0,121  0,021  Glutamate release inhibitor
0,110  0,010  Antitreponemal
0,133  0,035  Antineoplastic antibiotic
0,179  0,081  P-glycoprotein inhibitor
0,283  0,185  5 Hydroxytryptamine release inhibitor
0,143  0,047  Growth stimulant
0,181  0,086  Anesthetic general
0,114  0,020  Na+ K+ transporting ATPase inhibitor
0,146  0,054  M18 aspartyl aminopeptidase inhibitor
0,193  0,101  Antiglaucomic
0,128  0,037  Electron transport complex I inhibitor
0,252  0,162  Atherosclerosis treatment
0,167  0,077  Liver fibrosis treatment
0,193  0,103  Antineoplastic (lymphocytic leukemia)
0,127  0,038  DOPA decarboxylase inhibitor
0,131  0,042  Aldehyde dehydrogenase substrate
0,156  0,067  Antidote
0,136  0,047  Contraceptive female
0,146  0,057  Heat shock protein 70 antagonist
0,132  0,044  Chelator
0,153  0,067  Cyclooxygenase inhibitor
0,182  0,096  Antiviral (Ebola)
0,106  0,020  Beta tubulin antagonist
0,122  0,037  Prolactin inhibitor
0,098  0,013  Antimycoplasmal
0,124  0,040  Toll-Like receptor 4 antagonist
0,135  0,051  Antiviral (Papilloma)
0,092  0,008  Postcoital contraceptive
0,153  0,069  Antidiarrheal
0,195  0,112  Myocardial infarction treatment
0,108  0,026  Keratolytic
0,135  0,053  Skin irritative effect
0,122  0,040  Sphingomyelinase inhibitor
0,141  0,061  Cocaine dependence treatment
0,174  0,094  CYP2B6 inhibitor
0,140  0,063  Cyclooxygenase 1 inhibitor
0,098  0,021  Phosphodiesterase VI inhibitor
0,102  0,026  CDC25A inhibitor
0,162  0,087  Toxic, respiratory center
0,078  0,004  Sodium/glucose cotransporter 2 inhibitor
0,099  0,025  Narcotic antagonist
0,074  0,004  Sodium/glucose cotransporter inhibitor
0,188  0,118  Antidiabetic symptomatic
0,123  0,054  Photosensitizer
0,232  0,165  Toll-Like receptor 7 agonist
0,132  0,065  Antibacterial (Helicobacter pylori)
0,090  0,024  MAP kinase kinase 7 inhibitor
0,200  0,134  Transcription factor STAT3 inhibitor
0,096  0,031  Antiviral (Dengue virus)
0,110  0,045  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,086  0,021  Glutamate (mGluR7) antagonist
0,102  0,038  Topoisomerase II alpha inhibitor
0,125  0,061  Antineoplastic antimetabolite
0,231  0,167  Toll-Like receptor agonist
0,129  0,065  Carcinogenic, group 3
0,122  0,059  Constipation treatment
0,172  0,110  Antiulcerative
0,204  0,144  Antineoplastic (multiple myeloma)
0,131  0,071  Interleukin 4 antagonist
0,112  0,056  Antiprotozoal (Toxoplasma)
0,080  0,025  SULT2A1 substrate
0,136  0,082  MAP3K9 inhibitor
0,143  0,089  CF transmembrane conductance regulator agonist
0,090  0,036  Phosphofructokinase-1 inhibitor
0,070  0,017  Alpha-mannosidase inhibitor
0,092  0,038  Antibiotic
0,126  0,073  Antihelmintic (Trematoda)
0,100  0,047  Actinic keratosis treatment
0,059  0,006  Nucleoside transporters inhibitor
0,181  0,129  Vascular (periferal) disease treatment
0,070  0,018  Ryanodine receptor antagonist
0,107  0,055  Chronic obstructive bronchitis treatment
0,153  0,101  Phospholipase C inhibitor
0,093  0,042  mTOR complex 2 inhibitor
0,083  0,034  Glycine receptor agonist
0,069  0,021  Bcl-xL inhibitor
0,189  0,141  Antiviral (West Nile virus)
0,090  0,041  Estrogen-related receptor beta agonist
0,108  0,060  HDL-cholesterol increasing
0,066  0,018  Topoisomerase II beta inhibitor
0,097  0,049  Androgen antagonist
0,072  0,026  Transcription factor RelA inhibitor
0,109  0,063  Protein kinase C gamma inhibitor
0,049  0,004  Sodium/glucose cotransporter 1 inhibitor
0,095  0,050  Ornithine decarboxylase inhibitor
0,089  0,044  Glycine receptor antagonist
0,068  0,023  Glucosylceramidase inhibitor
0,064  0,020  Glucose-6-phosphate translocase inhibitor
0,154  0,110  Antiviral (Hepatitis)
0,102  0,059  Anabolic
0,119  0,076  Coagulant
0,077  0,036  Anticholelithogenic
0,050  0,010  Cholesterol absorption inhibitor
0,071  0,032  Antiviral (Parainfluenza)
0,048  0,009  Tubulin agonist
0,195  0,157  12-Lipoxygenase inhibitor
0,057  0,019  Mannosidase inhibitor
0,086  0,049  Thioredoxin reductase inhibitor
0,110  0,074  Antiviral (CMV)
0,061  0,026  Adenine nucleotide translocase inhibitor
0,090  0,055  Contraceptive male
0,065  0,030  Beta 2 adrenoreceptor agonist
0,091  0,057  Antiviral (Hepatitis A)
0,076  0,041  Amidase inhibitor
0,132  0,099  Protein-tyrosine phosphatase inhibitor
0,067  0,033  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,061  0,028  Thromboxane A2 antagonist
0,063  0,030  Thromboxane antagonist
0,075  0,042  HIV-1 integrase inhibitor
0,084  0,052  T cell inhibitor
0,092  0,059  Paget's disease treatment
0,061  0,029  Acetyl-CoA transferase 2 inhibitor
0,067  0,036  Aromatase inhibitor
0,107  0,076  Antitussive
0,139  0,107  Antiviral (Hepatitis C)
0,092  0,062  Protein kinase C zeta inhibitor
0,045  0,016  Glutamate (mGluR8) agonist
0,103  0,075  Protein-tyrosine phosphatase 1B inhibitor
0,137  0,110  Interleukin 6 antagonist
0,058  0,031  Thromboxane synthase inhibitor
0,049  0,022  Guanylate cyclase inhibitor
0,093  0,067  Bile acid receptor antagonist
0,055  0,030  Vanilloid 2 antagonist
0,052  0,027  Glucose-6-phosphate isomerase inhibitor
0,126  0,102  Insulin secretagoues
0,083  0,059  D-Ala-D-Ala ligase inhibitor
0,067  0,043  Leukotriene antagonist
0,113  0,089  Antihyperlipoproteinemic
0,044  0,020  Farnesoid X receptor agonist
0,061  0,037  Xanthine dehydrogenase inhibitor
0,066  0,043  Dopamine D1 antagonist
0,037  0,015  Prostaglandin agonist
0,083  0,062  Alpha 2 adrenoreceptor antagonist
0,086  0,065  Triose-phosphate isomerase inhibitor
0,044  0,023  Dopamine D5 agonist
0,035  0,016  Glutamate (mGluR3) agonist
0,080  0,061  Antispirochetal
0,040  0,021  Vanilloid 3 antagonist
0,114  0,094  Alkaline phosphatase inhibitor
0,088  0,069  Breast cancer-resistant protein inhibitor
0,060  0,041  Androgen agonist
0,051  0,032  Squalene epoxidase inhibitor
0,058  0,040  Lipocortins synthesis agonist
0,057  0,039  Fatty acid synthase inhibitor
0,066  0,049  Glutamate (mGluR6) antagonist
0,074  0,057  GABA B receptor agonist
0,044  0,028  Estradiol 17 beta-dehydrogenase inhibitor
0,047  0,032  Carbonic anhydrase VII inhibitor
0,109  0,095  Contraceptive
0,072  0,058  SULT1A2 substrate
0,045  0,032  Neuraminidase (Influenza A) inhibitor
0,025  0,012  GRP78 expression inhibitor
0,192  0,179  FMO3 substrate
0,110  0,097  NADPH oxidase inhibitor
0,062  0,049  Calcium channel P-type blocker
0,036  0,023  Phosphoglycerate kinase inhibitor
0,033  0,022  Catechol O-methyltransferase inhibitor
0,089  0,079  Tourette's syndrome treatment
0,024  0,014  Dopamine D1 agonist
0,049  0,039  Anesthetic inhalation
0,020  0,010  Antibiotic Anthracycline-like
0,075  0,065  Adrenaline agonist
0,060  0,051  Prolactin release inhibitor
0,063  0,055  Carbonic anhydrase VA inhibitor
0,155  0,146  Antiviral (HIV)
0,165  0,157  Peptidyltransferase inhibitor
0,060  0,053  Carbonic anhydrase V inhibitor
0,052  0,044  Sphingosine kinase 2 inhibitor
0,064  0,058  MDM2 inhibitor
0,045  0,039  Plasminogen activator inhibitor antagonist
0,050  0,044  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,043  0,037  Microtubule stabilization
0,100  0,094  Antiviral (Hepatitis B)
0,051  0,047  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,062  0,058  Endocannabinoid uptake inhibitor
0,030  0,026  ATP citrate lysase inhibitor
0,047  0,043  Protein 50S ribosomal subunit inhibitor
0,044  0,041  Carbonic anhydrase XIV inhibitor
0,054  0,051  Heat shock protein 90 beta antagonist
0,125  0,122  Dual specificity phosphatase 3 inhibitor
0,059  0,057  Beta adrenoreceptor antagonist
0,078  0,075  Transcription factor NF kappa B stimulant
0,050  0,048  Dopamine uptake inhibitor
0,059  0,057  Neuraminidase (influenza) inhibitor
0,059  0,058  Beta 3 adrenoreceptor antagonist
0,084  0,083  Dementia treatment
0,014  0,013  NMDA receptor phencyclidine site antagonist
0,009  0,008  Progesterone receptor A antagonist

